BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:11 PM
 | 
Apr 22, 2008
 |  BC Extra  |  Top Story

GSK to acquire Sirtris

GlaxoSmithKline (LSE:GSK; NYSE:GSK) will acquire Sirtris (NASDAQ:SIRT) for $22.50 per share, or about $720 million in cash. The price is an 84% premium to Sirtris' close of $12.23 on...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >